Rebamipide Tablets

An Liding ® Rebamipide Tablets

Medicare Category  B

[Drug Name]

       Generic name: Rebapart Tablets

[Indications]

       Improvement of gastric mucosal lesions (erosion, bleeding, congestion, edema) in acute gastritis and acute exacerbations of chronic gastritis.

       Gastric ulcer.

[Usage and Dosage]

       For gastritis-related gastric mucosal lesions: usual adult dose is 0.1 g, three times daily, orally.

       For gastric ulcer: usual adult dose is 0.1 g, three times daily (morning, evening, and before bedtime), orally.

[ Contraindications ]

       Contraindicated in patients with known hypersensitivity to this product.

[Specification]

       0.1 g

[Validity Period]

       36 months

[Approval Number]

       National Medical Approval Number: H20243604

Consultation hotline: +86 591 83512959